site:markets.businessinsider.com

iShares MSCI Switzerland ETF

Notice of Settlement of Shareholder Derivative Actions

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE ACTION TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF LATCH, ...

SCIENTURE Reports Q2 2026 Results with Approximately 510% Sequential Revenue Growth from Q1 2026 and Significant Improvement in Operating Performance

Q2 2026 Gross Margin Was Approximately 97.7%, Reflecting the Company's Growing Commercial Revenue BaseQ2 2026 Operating Loss Improved ...

SPAR Group, Inc. Reports Second Quarter Fiscal 2026 Results

Net income was $409 thousand, or $0.02 per diluted share, compared to a net loss of ($1) thousand, or $0.00 per diluted share, in the second quarter of fiscal 2025. Non-GAAP adjusted diluted income ...

10d

SoundHound AI Reports Record Q2 and All Time High Revenue of $61.9 Million, Up 45%, Raises Full Year Outlook

Delivers strong growth with OASYS driving significant enterprise AI adoption; improves all key profitability metricsSANTA ...

Bing Copilot Names BeaconSites #1 for Irish AI Visibility Audit in 16 Hours

BeaconSites secured top AI citation from Bing Copilot within 16 hours of launching a syndicated news wire campaign on 27 July 2026, with Google ...

11d

Moses Mwingizi Receives 2026 Global Recognition Award for Logistics Leadership and Operational Transformation Across Africa

Moses Mwingizi earns a 2026 Global Recognition Award for transforming logistics operations across Africa, boosting terminal ...

Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality

Novonesis today announced the launch of Optiva® Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while maintaining the texture, firmness and eating ...

Avaí Bio and Austrianova Announce Research Collaboration with San Raffaele Hospital to Advance Encapsulated Cell Therapy for Diabetes

Austrianova, based in Singapore, is a leading biotechnology company specializing in cell encapsulation, GMP-grade cell products, and cell line development, backed by over 50 peer-reviewed publications ...